User menu

Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.

Bibliographic reference Ho, Tony W ; Pearlman, Eric ; Lewis, Donald ; Hämäläinen, Mirja ; Connor, Kathryn ; et. al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design.. In: Cephalalgia : an international journal of headache, Vol. 32, no.10, p. 750-65 (2012)
Permanent URL http://hdl.handle.net/2078.1/143044
  1. Lipton R. B., Bigal M. E., Diamond M., Freitag F., Reed M. L., Stewart W. F., , Migraine prevalence, disease burden, and the need for preventive therapy, 10.1212/01.wnl.0000252808.97649.21
  2. ABU-ARAFEH ISHAQ, RAZAK SHEIK, SIVARAMAN BASKARAN, GRAHAM CATRIONA, Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies : Review, 10.1111/j.1469-8749.2010.03793.x
  3. Hamalainen M. L., Hoppu K., Valkeila E., Santavuori P., Ibuprofen or Acetaminophen for the Acute Treatment of Migraine in Children: A Double-blind, Randomized, Placebo-controlled, Crossover Study, 10.1212/wnl.48.1.103
  4. Lewis Donald W., Kellstein David, Dahl Georg, Burke Bonnie, Frank L. M., Toor S., Northam R. S., White L. W., Lawson L., Children's Ibuprofen Suspension for the Acute Treatment of Pediatric Migraine, 10.1046/j.1526-4610.2002.02180.x
  5. Lewis D., Ashwal S., Hershey A., Hirtz D., Yonker M., Silberstein S., Practice Parameter: Pharmacological treatment of migraine headache in children and adolescents: Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society, 10.1212/01.wnl.0000147332.41993.90
  6. Lewis Donald W., Winner Paul, Wasiewski Warren, The Placebo Responder Rate in Children and Adolescents, 10.1111/j.1526-4610.2005.05050.x
  7. Winner Paul, Rothner A. David, Wooten John D., Webster Chris, Ames Michael, Sumatriptan Nasal Spray in Adolescent Migraineurs: A Randomized, Double-Blind, Placebo-Controlled, Acute Study, 10.1111/j.1526-4610.2006.00339.x
  8. Linder Steven L., Mathew Ninan T., Cady Roger K., Finlayson Gary, Ishkanian Gary, Lewis Donald W., Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial, 10.1111/j.1526-4610.2008.01138.x
  9. Fernandes Ricardo, Ferreira Joaquim J., Sampaio Cristina, The Placebo Response in Studies of Acute Migraine, 10.1016/j.jpeds.2007.09.024
  10. Evers S, Marziniak M, Frese A, Gralow I, Placebo Efficacy in Childhood and Adolescence Migraine: An Analysis of Double-Blind and Placebo-Controlled Studies, 10.1111/j.1468-2982.2008.01752.x
  11. Winner Paul, Lewis Donald, Visser W. Hester, Jiang Kaihong, Ahrens Suzanne, Evans Judith K., on behalf of the Rizatriptan Adoles, Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Study, 10.1046/j.1526-4610.2002.02013.x
  12. Hester Visser W., Winner Paul, Strohmaier Kim, Klipfel Meghan, Peng Yahong, McCarroll Kathleen, Cady Roger, Lewis Donald, Nett Robert, , Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: Results From a Double-Blind, Single-Attack Study and Two Open-Label, Multiple-Attack Studies, 10.1111/j.1526-4610.2004.04171.x
  13. Ahonen K., Hamalainen M. L., Eerola M., Hoppu K., A randomized trial of rizatriptan in migraine attacks in children, 10.1212/01.wnl.0000238179.79888.44
  14. Maunuksela Eeva-Liisa, Olkkola Klaus T, Korpela Reijo, Measurement of pain in children with self-reporting and behavioral assessment, 10.1038/clpt.1987.123
  15. Fraser Iain P., Han Lingling, Han Tae H., Li Chi-Chung, Hreniuk David, Stoch S. Aubrey, Wagner John A., Linder Steven, Winner Paul, Pharmacokinetics and Tolerability of Rizatriptan in Pediatric Migraineurs in a Randomized Study, 10.1111/j.1526-4610.2011.02069.x
  16. Swan Suzanne K., Alcorn Harry, Rodgers Anthony, Hustad Carolyn M., Ramsey Karen E., Woll Susan, Skobieranda Franck, Pharmacokinetic Profile of Rizatriptan 10-mg Tablet and 10-mg Orally Disintegrating Tablet Administered With or Without Water in Healthy Subjects: An Open-Label, Randomized, Single-Dose, 3-Period Crossover Study, 10.1177/0091270005284194
  17. , Tfelt-Hansen P, Block G, Dahlöf C, Diener H-C, Ferrari MD, Goadsby PJ, Guidetti V, Jones B, Lipton RB, Massiou H, Meinert C, Sandrini G, Steiner T, Winter PBO, Guidelines for Controlled Trials of Drugs in Migraine: Second Edition, 10.1046/j.1468-2982.2000.00117.x
  18. Ferrari MD, Loder E, McCarroll KA, Lines CR, Meta-Analysis of Rizatriptan Efficacy in Randomized Controlled Clinical Trials, 10.1046/j.1468-2982.2001.00169.x
  19. Lewis D. W., Ashwal S., Dahl G., Dorbad D., Hirtz D., Prensky A., Jarjour I., Practice parameter: Evaluation of children and adolescents with recurrent headaches: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society, 10.1212/wnl.59.4.490